2008
(399) Low-dose ketamine for vasoocclusive pain in pediatric patients with sickle cell disease: A case series
Zempsky W, Loiselle K, Hagstrom J, Kain Z. (399) Low-dose ketamine for vasoocclusive pain in pediatric patients with sickle cell disease: A case series. Journal Of Pain 2008, 9: 75. DOI: 10.1016/j.jpain.2008.01.323.Peer-Reviewed Original Research
2007
(915) Risk factors for extended length of hospitalization in children with vasoocclusive episodes secondary to sickle cell disease
Zempsky W, Loiselle K, Blake G, Hagstrom J, Schechter N, Kain Z. (915) Risk factors for extended length of hospitalization in children with vasoocclusive episodes secondary to sickle cell disease. Journal Of Pain 2007, 8: s79. DOI: 10.1016/j.jpain.2007.02.323.Peer-Reviewed Original Research(922) Pain assessment and therapeutic intervention during inpatient hospitalizations in children with sickle cell disease: A retrospective study
Zempsky W, Loiselle K, Blake G, Hagstrom J, Schechter N, Kain Z. (922) Pain assessment and therapeutic intervention during inpatient hospitalizations in children with sickle cell disease: A retrospective study. Journal Of Pain 2007, 8: s81. DOI: 10.1016/j.jpain.2007.02.330.Peer-Reviewed Original Research(914) How does hospitalization frequency relate to pain, opiate use, and length of stay in children with sickle cell disease?
Zempsky W, Loiselle K, Blake G, Hagstrom J, Schechter N, Kain Z. (914) How does hospitalization frequency relate to pain, opiate use, and length of stay in children with sickle cell disease? Journal Of Pain 2007, 8: s79. DOI: 10.1016/j.jpain.2007.02.322.Peer-Reviewed Original Research